Log In
Print this Print this

Xience nano Everolimus Eluting Coronary Stent System

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionEverolimus-eluting coronary stent system utilizing a durable polymer for small vessels
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today